Limited partnership

Global and China Autonomous Driving Map Industry Report 2024: How are Players Responding to the Development of New-Generation Autonomous Driving Maps - ResearchAndMarkets.com

Retrieved on: 
Thursday, March 7, 2024

Autonomous Driving Map Industry Report, 2024 highlights the following:

Key Points: 
  • Autonomous Driving Map Industry Report, 2024 highlights the following:
    Autonomous driving map (formulation of policies, regulations, standards, etc.
  • );
    Application scenarios of intelligent driving map (high-speed autonomous driving of passenger cars, low-speed parking, autonomous human carrying, autonomous object carrying, etc.
  • 1 Status Quo of Policies, Standards and Regulations Concerning Autonomous Driving Map
    2.2 Classification of Autonomous Driving Maps: Navigation Map (SD Map)
    2.3 Classification of Autonomous Driving Maps: ADAS Map (SD Pro MAP)
    2.4 Classification of Autonomous Driving Maps: HD Map
    2.5 How Do Conventional Map Providers Make Layout Driven by Urban NOA?
  • 4.3 Intelligent Driving Map Application in Sub-scenarios: Low-speed Parking of Passenger Cars
    4.4 Intelligent Driving Map Application in Sub-scenarios: Autonomous Object Carrying
    4.5 Intelligent Driving Map Application in Sub-scenarios: Autonomous Human Carrying

Global and China Autonomous Driving Map Industry Report 2024 Featuring 14 Chinese and Foreign Map Providers and 4 HD Map Technology Companies

Retrieved on: 
Tuesday, March 5, 2024

DUBLIN, March 5, 2024 /PRNewswire/ -- The "Autonomous Driving Map Industry Report, 2024" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, March 5, 2024 /PRNewswire/ -- The "Autonomous Driving Map Industry Report, 2024" report has been added to ResearchAndMarkets.com's offering.
  • );
    Application scenarios of intelligent driving map (high-speed autonomous driving of passenger cars, low-speed parking, autonomous human carrying, autonomous object carrying, etc.
  • 1 Status Quo of Policies, Standards and Regulations Concerning Autonomous Driving Map
    2.2 Classification of Autonomous Driving Maps: Navigation Map (SD Map)
    2.3 Classification of Autonomous Driving Maps: ADAS Map (SD Pro MAP)
    2.4 Classification of Autonomous Driving Maps: HD Map
    2.5 How Do Conventional Map Providers Make Layout Driven by Urban NOA?
  • 4.3 Intelligent Driving Map Application in Sub-scenarios: Low-speed Parking of Passenger Cars
    4.4 Intelligent Driving Map Application in Sub-scenarios: Autonomous Object Carrying
    4.5 Intelligent Driving Map Application in Sub-scenarios: Autonomous Human Carrying

BioVaxys Acquires All Intellectual Property, Immunotherapeutics Platform Technology, and Clinical Stage Assets of the Former IMV Inc.

Retrieved on: 
Monday, February 12, 2024

HIMV will also be entitled to appoint an observer to BioVaxys's Board of Directors.

Key Points: 
  • HIMV will also be entitled to appoint an observer to BioVaxys's Board of Directors.
  • The DPX™ antigen delivery platform acquired by BioVaxys is designed to stimulate a specific, coordinated and persistent anti-tumor immune response, improving the lives of patients with solid or hematological cancers.
  • These elements foster maturation of antigen presenting cells as well as robust activation of CD8 T cell effector and memory function.
  • Findings showed clinical benefit to patients with recurrent ovarian cancer, regardless of platinum sensitivity or BRCA mutational status.

BioVaxys Acquires All Intellectual Property, Immunotherapeutics Platform Technology, and Clinical Stage Assets of the Former IMV Inc.

Retrieved on: 
Monday, February 12, 2024

HIMV will also be entitled to appoint an observer to BioVaxys's Board of Directors.

Key Points: 
  • HIMV will also be entitled to appoint an observer to BioVaxys's Board of Directors.
  • The DPX™ antigen delivery platform acquired by BioVaxys is designed to stimulate a specific, coordinated and persistent anti-tumor immune response, improving the lives of patients with solid or hematological cancers.
  • These elements foster maturation of antigen presenting cells as well as robust activation of CD8 T cell effector and memory function.
  • Findings showed clinical benefit to patients with recurrent ovarian cancer, regardless of platinum sensitivity or BRCA mutational status.

Holiday Island Holdings, Inc. is Developing Multiple Income Producing Oil Wells in West Texas

Retrieved on: 
Tuesday, January 30, 2024

HOLIDAY ISLAND, Ark., Jan. 30, 2024 (GLOBE NEWSWIRE) -- Holiday Island Holdings, Inc. (OTC: HIHI) (Pending name change to EP3Oil) – operating in the Secondary Recovery of Oil & Gas Industry – released the news today that Holiday Island Holdings finalized a deal for multiple Oil Wells in West Texas Permian Basin.

Key Points: 
  • HOLIDAY ISLAND, Ark., Jan. 30, 2024 (GLOBE NEWSWIRE) -- Holiday Island Holdings, Inc. (OTC: HIHI) (Pending name change to EP3Oil) – operating in the Secondary Recovery of Oil & Gas Industry – released the news today that Holiday Island Holdings finalized a deal for multiple Oil Wells in West Texas Permian Basin.
  • Glenn Klinker (CEO Holiday Island Holdings) has finalized a deal to develop multiple wells with Benchmark Petroleum and Rock Oil in the Permian basin of Texas.
  • Alverico Asencio, VP of Holiday Island Holdings, has strong partnerships in South America and the United States, and he is confident in his ability to fund these endeavors.
  • Asencio is quoted, “I have been inundated with multiple inquiries into the purchase of Oil Opportunities, especially from the Dominican Republic and Ecuador.

EQS-News: paragon founder bundles shares in family holding

Retrieved on: 
Tuesday, January 30, 2024

Klaus Dieter Frers has transferred his 49.3% share package in paragon GmbH & Co. KGaA to Frers Family Office GmbH

Key Points: 
  • Klaus Dieter Frers has transferred his 49.3% share package in paragon GmbH & Co. KGaA to Frers Family Office GmbH
    Frers Family Office GmbH is now the largest shareholder of paragon GmbH & Co. KGaA
    Delbrück, January 26, 2024 - The founder of paragon GmbH & Co. KGaA [ISIN DE0005558696], Klaus Dieter Frers, has informed the company that both he and his wife have transferred all paragon shares they own to Frers Family Office GmbH.
  • According to Klaus Dieter Frers, Managing Director of the general partner of paragon GmbH & Co. KGaA, paragon GmbH, the bundling had been planned for some time, but could only be implemented after the repurchase of a block of shares last year.
  • Mr. Klaus Dieter Frers holds approximately 98.6% of the shares in Frers Family Office GmbH, which is based in Delbrück.
  • Klaus Dieter Frers is also Managing Director of the company, which functions as a family holding company.

Percent Wraps 2023 with Significant Growth and Crosses $1 Billion Threshold in Marketplace Issuance

Retrieved on: 
Wednesday, January 24, 2024

Percent , the platform that has created the modern private credit marketplace, closed out 2023 with a record-setting performance.

Key Points: 
  • Percent , the platform that has created the modern private credit marketplace, closed out 2023 with a record-setting performance.
  • Notably, the platform crossed the $1 billion threshold in marketplace issuance across more than 550 deals (as of January 9, 2024) since the company’s founding in 2018.
  • In 2023, Percent raised $30M in a Series B round that helped fuel the company’s growth and mission.
  • Total AUM saw a 35.7% increase YOY from 2022 to 2023, and has increased an average of 41.4% yearly since 2021.

Myrobalan Therapeutics Completes Series A Financing of $24 Million to Develop Potentially First-in-Class CNS Therapeutics with Restorative Potential

Retrieved on: 
Wednesday, January 10, 2024

Myrobalan has the potential to overcome such obstacles with the development of highly selective, brain-penetrant, orally available compounds against promising novel targets involved in demyelination and neuroinflammation.

Key Points: 
  • Myrobalan has the potential to overcome such obstacles with the development of highly selective, brain-penetrant, orally available compounds against promising novel targets involved in demyelination and neuroinflammation.
  • These currently untreatable disease mechanisms have been linked to multiple sclerosis (MS), Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS), and several rare neurological conditions.
  • “Our deep understanding of remyelination and neuroinflammation has broad application in high-unmet need CNS diseases,” said Dr. Jing Wang, CEO & Co-Founder, Myrobalan Therapeutics.
  • Myrobalan Therapeutics' unique strategy holds great promise in overcoming challenges associated with central nervous system diseases.

Cheetah Mobile Further Invests in Beijing OrionStar

Retrieved on: 
Friday, January 12, 2024

BEIJING, Jan. 12, 2024 /PRNewswire/ -- Cheetah Mobile Inc. (NYSE: CMCM) ("Cheetah Mobile" or the "Company"), a leading internet company, today announced that the Company, through two of its wholly-owned subsidiaries, has made an additional investment in Beijing OrionStar Technology Co., Ltd. ("Beijing OrionStar"), in which the Company held 72.91% equity interest before the investment.

Key Points: 
  • BEIJING, Jan. 12, 2024 /PRNewswire/ -- Cheetah Mobile Inc. (NYSE: CMCM) ("Cheetah Mobile" or the "Company"), a leading internet company, today announced that the Company, through two of its wholly-owned subsidiaries, has made an additional investment in Beijing OrionStar Technology Co., Ltd. ("Beijing OrionStar"), in which the Company held 72.91% equity interest before the investment.
  • The Company, through a wholly-owned subsidiary, made an investment of US$16.7 million in Beijing OrionStar.
  • Concurrently, Beijing Kingsoft Internet Security Software Co., Ltd. ("Beijing Security"), a wholly-owned subsidiary of the Company, exercised its right under the convertible loan with principal amount of RMB100 million that it provided to Beijing OrionStar in 2021 to convert all of the principal and the accrued interest into Beijing OrionStar's equity interest.
  • Additionally, Gongqingcheng Orion Industrial Investment Center (Limited Partnership) (the "Fund") made an investment of RMB150 million, or approximately US$20.9 million, into Beijing OrionStar.

Evolve Transition Infrastructure Reports Exercise of Right to Purchase Common Units

Retrieved on: 
Monday, January 8, 2024

HOUSTON, Jan. 08, 2024 (GLOBE NEWSWIRE) -- Evolve Transition Infrastructure LP (NYSE American: SNMP) (the “Partnership”) announced today that Evolve Transition Infrastructure GP LLC, the general partner of the Partnership (the “General Partner”), has elected to exercise the right to purchase all of the issued and outstanding common units representing limited partner interests (“Common Units”) in the Partnership not already owned by the General Partner or its controlled affiliates (the “Transaction Units”) pursuant to Section 15.1 of the Partnership’s Third Amended and Restated Agreement of Limited Partnership, as amended (the “Partnership Agreement”).

Key Points: 
  • HOUSTON, Jan. 08, 2024 (GLOBE NEWSWIRE) -- Evolve Transition Infrastructure LP (NYSE American: SNMP) (the “Partnership”) announced today that Evolve Transition Infrastructure GP LLC, the general partner of the Partnership (the “General Partner”), has elected to exercise the right to purchase all of the issued and outstanding common units representing limited partner interests (“Common Units”) in the Partnership not already owned by the General Partner or its controlled affiliates (the “Transaction Units”) pursuant to Section 15.1 of the Partnership’s Third Amended and Restated Agreement of Limited Partnership, as amended (the “Partnership Agreement”).
  • The General Partner will purchase the Transaction Units on February 16, 2024 (the “Purchase Date”) for a cash purchase price of $1.389285 per Transaction Unit.
  • As of the Purchase Date, all rights of the holders of the Transaction Units will cease, except for the right to receive payment of the purchase price.
  • Upon completion of the purchase on the Purchase Date, the General Partner and its affiliates will own, directly or indirectly, 100% of the Common Units.